A Renal Transplantation and Hemodialysis Cost-Utility Analysis in Patients with End-Stage Renal Disease.
10.4285/jkstn.2010.24.3.173
- Author:
Soon Il KIM
1
;
Yu Seun KIM
;
Myoung Soo KIM
;
Eun Cheol PARK
;
Kyung Ock JEON
;
Sun young SON
;
Myung Il HAHM
;
Hoo Yeon LEE
Author Information
1. Department of Surgery and the Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Cost-effectiveness analysis;
Cost-utility analysis;
Renal transplantation;
Hemodialysis;
End-stage renal disease (ESRD)
- MeSH:
Dialysis;
Health Care Costs;
Humans;
Kidney Failure, Chronic;
Kidney Transplantation;
Korea;
Quality-Adjusted Life Years;
Renal Dialysis;
Transplants
- From:The Journal of the Korean Society for Transplantation
2010;24(3):173-181
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The purpose of this study was to examine the cost-effectiveness of renal transplantation and hemodialysis among end-stage renal disease patients. METHODS: Empirical data on treatment costs were collected from five hospitals in Korea. We used European Renal Association-European Dialysis and Transplant Association registry data for transition probability. Quality adjusted life year (QALY) values were derived from the literature. A Markov model was used for predicting the cost utility of transplantation and hemodialysis over a 10-year period. RESULTS: Renal transplantation was less costly and resulted in a better outcome than hemodialysis. The cost per QALY gained was 19,450 thousand won in transplantation patients, whereas it was 36,514 thousand won per QALY gained in hemodialysis patients. CONCLUSIONS: Although the cost of the first year after transplantation was expensive, transplantation was more effective over 2 years and was less costly than hemodialysis. The results suggest that transplantation is more cost-effective than hemodialysis in Korea.
